El Salvador vs Switzerland: Share of one-year-olds vaccinated against Haemophilus influenzae type B
El Salvador
95.0%
in 2024
Switzerland
95.0%
in 2024
El Salvador rank
57th
Switzerland rank
57th
Share of one-year-olds vaccinated against Haemophilus influenzae type B over time
- El Salvador
- Switzerland
How they compare
El Salvador currently reports 95.0% against 95.0% in Switzerland, a difference of 0.0%.
The two have swapped places 12 times across 23 shared years of data; in 2002 it was Switzerland ahead.
El Salvador ranks 57th and Switzerland ranks 57th of 192 countries.
Switzerland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | El Salvador | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 92.2% | 92.8% | 0.5% | Switzerland |
| 2010s | 92.5% | 95.0% | 2.5% | Switzerland |
| 2020s | 94.4% | 95.0% | 0.6% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of one-year-olds vaccinated against haemophilus influenzae type b, El Salvador or Switzerland?
- El Salvador, at 95.0% against 95.0% in Switzerland as of 2024.
- What is the difference in share of one-year-olds vaccinated against haemophilus influenzae type b between El Salvador and Switzerland?
- 0.0%, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and Switzerland?
- 23 years are reported by both, from 2002 to 2024.
- How do El Salvador and Switzerland rank globally for share of one-year-olds vaccinated against haemophilus influenzae type b?
- El Salvador ranks 57th and Switzerland ranks 57th of 192 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Share of one-year-olds vaccinated against Haemophilus influenzae type B. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had three doses of Haemophilus influenzae type b vaccine in a given year.